obsolete_porphyria: ['A diverse group of metabolic diseases characterized by errors in the biosynthetic pathway of HEME in the LIVER, the BONE MARROW, or both. They are classified by the deficiency of specific enzymes, the tissue site of enzyme defect, or the clinical features that include neurological (acute) or cutaneous (skin lesions). Porphyrias can be hereditary or acquired as a result of toxicity to the hepatic or erythropoietic marrow tissues.']
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
382 |
4. Check minimum number of eventsNone |
382 |
5. Include endpoints |
420 |
6. Filter based on genotype QC (FinnGen only) |
420 |
Control definitions (FinnGen only)
- Control exclude
- E4_METABOLIA
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- E70-E90
- Name in latin
- Perturbationes metabolismi porphyrini et bilirubini
Similar endpoints
↥List of similar endpoints to
Disorders of porphyrin and bilirubin metabolism
based on the number of shared cases.
Similar with more cases:
- Metabolic disorders
- Endocrine, nutritional and metabolic diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3518 | 1459 | 2032 |
| Only index persons | 3166 | 1332 | 1834 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.04 | 0.06 |
| Only index persons | 0.06 | 0.05 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 38.30 | 39.37 | 37.32 |
| Only index persons | 37.26 | 39.00 | 36.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 420 | 182 | 238 |
| Unadjusted period prevalence (%) | 0.09 | 0.06 | 0.10 |
| Median age at first event (years) | 44.48 | 42.31 | 46.14 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 374
- Matched controls
- 3740
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
E80.4
ICD-10 Finland
Gilbert syndrome
+∞
262.5
220
*
E80.2
ICD-10 Finland
Other porphyria
+∞
46.9
44
*
E80.1
ICD-10 Finland
Porphyria cutanea tarda
+∞
31.7
30
*
E80.7
ICD-10 Finland
Disorder of bilirubin metabolism, unspecified
+∞
28.5
27
*
E80.0
ICD-10 Finland
Hereditary erythropoietic porphyria
+∞
26.4
25
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
20.0
22.2
33
18
27350
ICD-8 Finland
Other and unspecified congenital disorders of metabolism, Icterus intermittens juvenilis
+∞
16.8
16
*
E80.6
ICD-10 Finland
Other disorders of bilirubin metabolism
+∞
16.8
16
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
15.6
156
813
2774A
ICD-9 Finland
Other and unspecified disorders of metabolism, Disorders of bilirubin excretion[SYNDROMA GILBERT]
+∞
13.6
13
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
12.3
119
592
57308
ICD-8 Finland
Other diseases of liver, Alii definiti
123.6
11.5
12
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.5
10.2
48
150
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.9
9.7
62
239
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.4
9.1
44
141
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
9.0
90
447
UJF32
NOMESCO Finland
Coloscopy
2.2
8.7
96
499
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
28.2
8.5
11
*
27311
ICD-8 Finland
Other and unspecified congenital disorders of metabolism, Porphyria acuta intermittens
+∞
8.4
8
*
E87.6
ICD-10 Finland
Hypokalaemia
22.6
8.1
11
5
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.2
7.2
78
397
C10AC01
ATC
colestyramine; oral
6.8
7.2
17
26
A06AC01
ATC
ispaghula (psylla seeds); oral
2.1
7.2
89
482
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
7.2
91
500
FN1AD
NOMESCO Finland
CT of coronary arteries
11.2
6.8
12
11
R01AD12
ATC
fluticasone furoate; nasal
1.9
6.7
108
648
A02BC02
ATC
pantoprazole; systemic
1.8
6.5
220
1678
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
2.9
6.4
38
142
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
6.3
143
960
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
149
369
5.71
60.07
4.0
3.2
umol/l
11.2
8.6
0.74
140
323
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
291
1637
3.53
32.23
8.5
6.4
umol/l
27.1
12.4
15.74
282
1558
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
53
113
5.22
24.09
1.8
2.2
g/l
0.9
1.4
5.12
46
98
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
202
1077
2.69
21.73
4.4
3.2
u/l
34.0
32.8
0.25
190
1027
(3005719) IgG [Mass/volume] in Serum or Plasma
81
260
3.62
21.47
3.4
2.4
g/l
10.5
10.2
0.29
75
239
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
84
279
3.51
21.12
3.6
2.7
g/l
0.2
0.2
0.95
78
262
(3028026) IgM [Mass/volume] in Serum or Plasma
71
211
3.85
21.06
1.8
1.6
g/l
1.1
1.5
0.64
64
190
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
339
2442
3.01
18.48
10.4
7.3
u/l
80.1
78.0
0.42
325
2292
(3024561) Albumin [Mass/volume] in Serum or Plasma
207
1227
2.35
16.43
6.6
4.8
g/l
37.5
36.2
3.03
198
1153
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
84
322
3.01
16.43
5.1
4.7
u/l
213.4
245.5
2.21
78
310
(3032080) INR in Blood by Coagulation assay
193
1143
2.27
14.97
9.5
7.7
inr
1.2
1.2
0.27
50
327
(42870588) Differential panel, method unspecified - Blood
184
1070
2.28
14.90
7.5
6.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
314
2294
2.46
14.51
4.8
3.1
u/l
50.5
45.7
0.58
307
2170
(3002030) Lymphocytes/100 leukocytes in Blood
241
1580
2.23
14.38
7.8
6.3
%
29.6
28.7
0.69
227
1487
(3018010) Neutrophils/100 leukocytes in Blood
238
1555
2.22
14.29
7.2
6.1
%
55.8
56.3
0.27
226
1473
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
34
78
4.65
14.07
1.4
1.6
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
225
1456
2.17
13.61
7.9
6.5
mmol/l
1.2
1.2
0.00
195
1252
(3019069) Monocytes/100 leukocytes in Blood
233
1531
2.17
13.52
8.1
6.6
%
9.0
8.6
0.93
223
1446
(3001122) Ferritin [Mass/volume] in Serum or Plasma
211
1356
2.12
12.72
4.3
2.6
ug/l
154.3
136.7
0.55
202
1257
(3006504) Eosinophils/100 leukocytes in Blood
229
1520
2.11
12.65
7.9
6.3
%
2.8
2.9
0.48
219
1421
(3022096) Basophils/100 leukocytes in Blood
223
1475
2.09
12.32
7.9
6.4
%
0.7
0.7
0.29
212
1384
(3019198) Lymphocytes [#/volume] in Blood
244
1685
2.07
11.81
7.5
6.2
e9/l
1.8
1.9
0.83
223
1497
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
22
40
5.75
11.76
1.0
1.0
g/l
1.4
1.4
0.12
22
35
(3037522) Nuclear Ab [Titer] in Serum
94
447
2.42
11.76
1.3
1.4
titre
829.5
430.6
0.55
19
89
(3013115) Eosinophils [#/volume] in Blood
244
1694
2.05
11.53
7.7
6.6
e9/l
0.2
0.2
1.87
220
1497
(3007164) IgA [Mass/volume] in Serum or Plasma
123
665
2.20
11.35
1.7
1.4
g/l
2.1
2.4
1.30
88
404
(3001604) Monocytes [#/volume] in Blood
236
1631
2.02
11.16
7.6
6.1
e9/l
0.6
0.6
0.36
209
1416
(3013707) Erythrocyte sedimentation rate by Westergren method
312
2392
2.18
11.05
5.0
4.0
mm/h
9.8
10.4
0.36
296
2221
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
187
1200
2.01
10.81
3.2
2.2
nmol/l
78.1
74.4
1.11
176
1092
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
21
40
5.47
10.70
1.1
1.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
235
1638
1.99
10.67
7.6
6.2
e9/l
0.0
0.0
0.23
209
1424
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
158
960
2.04
10.61
3.0
2.3
u/l
58.8
59.0
0.03
148
892
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
199
1323
1.96
10.23
8.1
6.2
mmol/l
1.2
1.2
1.30
187
1218
(3013650) Neutrophils [#/volume] in Blood by Automated count
256
1858
1.97
10.11
11.4
9.9
e9/l
3.8
4.0
0.56
226
1638
(3012095) Magnesium [Moles/volume] in Serum or Plasma
88
457
2.17
8.76
3.9
4.5
mmol/l
0.8
0.8
0.51
81
434
(3017143) Hepatitis C virus Ab [Presence] in Serum
84
431
2.19
8.61
1.8
1.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
116
673
2.00
8.58
2.3
1.8
mg/l
1.2
1.1
0.11
73
507
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
122
732
1.94
8.13
1.3
1.3
u/ml
1.8
1.9
0.03
28
191
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
137
867
1.86
7.70
2.1
2.0
u/l
215.3
211.2
0.03
127
823
(3003458) Phosphate [Moles/volume] in Serum or Plasma
70
351
2.19
7.55
9.2
6.2
mmol/l
1.1
1.1
0.03
65
330
(3023520) Reticulocytes [#/volume] in Blood
53
237
2.41
7.46
3.0
2.9
e9/l
76.4
70.5
0.58
43
185
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
117
718
1.87
7.17
2.9
2.1
mg/l
3.4
3.1
0.31
103
631
(3044640) Blood type and Crossmatch panel - Blood
142
949
1.75
6.47
2.5
2.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
68
365
2.03
6.11
1.3
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
379
3380
2.24
5.87
18.4
12.1
mg/l
17.8
23.2
3.82
302
2575
(3018418) pH of Serum or Plasma
128
853
1.72
5.79
5.7
3.7
ph
7.4
7.4
0.32
27
171
(3037467) Urinalysis macro (dipstick) panel - Urine
271
2193
1.66
5.73
5.2
3.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
90
543
1.84
5.70
1.6
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
113
735
1.74
5.54
2.4
2.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
120
796
1.71
5.48
2.5
3.2
ng/l
2197.6
1034.1
0.41
100
669
(3019309) Folate [Moles/volume] in Red Blood Cells
82
491
1.83
5.30
1.9
1.6
nmol/l
1040.5
1207.2
0.74
66
386
(3018095) Leukocytes [#/volume] in Urine
152
1082
1.63
5.27
4.2
3.5
e6/l
51.5
111.1
0.91
113
768
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
9
9
10.19
5.05
1.6
2.1
u/l
172.7
216.2
—
9
9
(3013826) Glucose [Moles/volume] in Serum or Plasma
228
1801
1.58
5.04
5.4
4.8
mmol/l
6.5
6.6
0.27
218
1674
(3019225) pH of Specimen
53
281
2.01
4.91
5.0
3.7
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
277
2299
1.60
4.89
3.5
3.2
—
—
—
0
0
(4035726)
48
248
2.06
4.77
1.6
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
22
80
2.85
4.69
1.4
1.6
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
288
2425
1.60
4.67
4.0
3.5
pmol/l
14.8
14.7
0.29
268
2213
(3026493) Urate [Moles/volume] in Serum or Plasma
117
801
1.64
4.65
3.5
2.6
umol/l
350.6
5083.1
2.48
103
698
(40768797) Stomach Pathology biopsy report
68
400
1.84
4.64
1.2
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
75
459
1.77
4.49
2.1
2.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
137
985
1.58
4.42
5.4
3.1
mmol/l
2.4
2.4
0.15
122
868
(3023103) Potassium [Moles/volume] in Serum or Plasma
376
3417
1.96
4.38
20.3
13.7
mmol/l
3.9
4.0
1.58
369
3319
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
12
7.64
4.37
1.7
1.0
ug/l
9.1
7.9
—
9
12
(3002582) Erythrocytes [#/volume] in Urine
130
926
1.58
4.35
3.6
3.0
e6/l
16.6
145.7
1.15
106
720
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
72
2.87
4.35
1.5
1.5
ug/g
315.7
265.0
—
7
40
(3000494) Fungus identified in Specimen by Culture
65
386
1.81
4.29
2.5
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
68
414
1.77
4.13
2.7
2.4
ug/g
85.1
106.4
0.44
57
332
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
21
80
2.71
4.13
1.4
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
50
279
1.90
4.01
3.1
4.5
ug/l
3.2
44.4
0.84
33
233
(3021879) Hepatitis B virus core Ab [Presence] in Serum
50
279
1.90
4.01
1.6
1.5
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
151
1132
1.52
3.96
4.1
3.1
ng/l
22.3
34.4
1.13
99
728
(36304419) Bacteria [Presence] in Urine
118
841
1.56
3.88
3.7
3.0
—
—
—
0
0
(3013512) EKG study
123
885
1.55
3.88
4.2
3.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
53
305
1.84
3.87
2.6
2.5
u/l
26.6
33.2
1.03
45
264
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
76
487
1.68
3.85
2.0
1.9
%
1.6
1.4
0.78
62
438
(3026782) Osmolality of Urine
85
561
1.65
3.85
2.9
2.5
mosm/kgh2o
544.7
582.3
0.68
74
475
(3045142) Bone marrow Pathology biopsy report
12
34
3.60
3.79
1.3
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
333
2961
1.60
3.73
4.8
4.2
mu/l
2.0
1.9
0.39
310
2723
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
84
558
1.63
3.70
1.8
1.7
pmol/l
399.3
424.0
0.36
66
472
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
8
12
6.77
3.69
2.0
2.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
9
16
5.72
3.67
1.0
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
372
3408
1.80
3.66
19.9
13.5
mmol/l
139.9
139.7
0.65
367
3314
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
30
144
2.17
3.63
7.2
5.1
mmol/l
24.8
24.1
0.38
25
128
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
153
1169
1.49
3.60
2.4
1.9
pmol/l
94.9
97.5
0.33
92
641
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
14
46
3.11
3.56
1.3
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
63
2.77
3.53
1.1
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
47
270
1.83
3.46
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
349
3159
1.62
3.40
15.5
10.9
ml/min/173m2
83.4
85.1
0.71
307
2585
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
10
27
3.77
3.37
1.7
2.6
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
25
115
2.25
3.36
1.2
1.8
—
173.3
—
0
6
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
14
5.80
3.35
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
14
5.80
3.35
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
21
90
2.40
3.30
1.4
1.3
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
144
1105
1.46
3.25
4.0
3.0
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
46
268
1.80
3.25
6.3
3.9
mmol/l
3.0
2.2
0.43
34
211
(3052851) Hemolysis interference index of Serum or Plasma
20
85
2.42
3.20
2.2
2.9
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
20
85
2.42
3.20
1.1
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
160
1257
1.44
3.18
2.5
2.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
11
34
3.30
3.08
2.3
2.6
nmol/l
1.9
2.8
1.09
11
34
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
75
507
1.58
3.06
4.3
2.9
mmol/l
2.4
2.4
0.36
68
452
(40760892) CBC W Ordered Manual Differential panel - Blood
105
767
1.49
3.01
5.3
4.9
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
12
40
3.06
2.99
1.6
2.2
e9/l
1.5
1.1
—
7
19
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
36
200
1.88
2.96
5.0
4.2
mmol/l
2.2
1.7
0.29
25
161
(3009343) pH of Capillary blood
37
208
1.85
2.94
4.9
4.1
ph
7.4
7.4
—
5
26
(3030467) Casts [#/volume] in Urine by Automated count
115
860
1.46
2.93
3.7
3.0
e6/l
0.1
0.4
3.29
92
648
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
89
2.31
2.91
1.4
1.3
u/ml
231.1
261.2
—
10
54
(40758558) Short blood count panel - Blood
107
791
1.47
2.89
10.0
7.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
33
181
1.89
2.83
3.2
2.3
—
—
—
0
0
(3002256) Pathology report gross observation
60
393
1.61
2.79
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
90
649
1.49
2.74
1.7
1.6
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
14
54
2.65
2.73
2.1
1.8
g/l
0.7
0.9
0.22
14
39
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
76
529
1.53
2.73
2.9
2.8
e6/l
0.8
1.0
0.31
42
310
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
34
191
1.85
2.72
1.9
1.5
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
6
10
6.07
2.70
1.0
1.2
%
139.5
158.0
—
6
10
(3023368) Bacteria identified in Blood by Culture
106
796
1.44
2.62
5.7
4.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
24
121
2.04
2.61
5.7
4.6
g/l
0.1
0.3
1.52
14
54
(3026008) Bacteria identified in Urine by Culture
105
789
1.44
2.58
3.7
2.7
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
21
101
2.14
2.57
1.2
1.2
—
1.2
—
0
5
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
62
2.47
2.57
1.1
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
52
336
1.63
2.56
23.2
20.9
inr
1.6
1.3
—
8
49
(3035350) Ketones [Presence] in Urine by Test strip
189
1572
1.37
2.56
4.2
3.2
estimate
0.0
0.0
0.00
35
306
(4062490)
10
33
3.08
2.54
2.2
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
7
16
4.43
2.48
1.3
2.3
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
191
1597
1.36
2.48
4.3
3.3
estimate
0.0
0.0
0.00
36
297
(3021601) Nitrite [Presence] in Urine by Test strip
189
1579
1.36
2.46
6.2
4.5
estimate
0.0
0.0
0.50
36
304
(3021589) Normoblasts [#/volume] in Blood
179
1483
1.36
2.46
13.4
8.9
e9/l
0.0
0.0
0.62
144
1207
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
31
175
1.83
2.45
11.5
8.7
mmol/l
24.2
24.8
0.51
31
175
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
8
22
3.69
2.37
5.9
4.4
%
85.4
90.8
—
8
22
(3029075) Extractable nuclear Ab panel - Serum
7
17
4.17
2.37
1.1
1.0
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
7
17
4.17
2.37
36.9
28.7
ug/l
6.5
7.5
—
7
12
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
7
17
4.17
2.37
2.1
2.8
nmol/l
113.7
61.3
—
7
17
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
174
1442
1.35
2.36
5.0
3.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
77
558
1.47
2.28
1.3
1.3
iu/ml
27.3
36.0
0.28
15
174
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
100
2.05
2.24
3.6
1.9
g/l
3.3
3.8
1.62
14
78
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
20
100
2.05
2.24
3.6
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
345
3193
1.45
2.24
4.8
4.1
mmol/l
5.7
5.9
1.68
328
2926
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
355
3304
1.48
2.23
4.5
4.0
mmol/l
4.5
4.7
2.41
345
3074
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
9
5.61
2.22
2.2
4.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
11
42
2.66
2.20
12.6
2.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
24
3.38
2.19
1.5
1.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
7
19
3.73
2.16
9.1
7.0
%
10.7
11.7
—
7
19
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
17
81
2.15
2.15
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
138
1.86
2.14
1.4
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
25
3.24
2.10
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
25
3.24
2.10
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
110
1.96
2.09
1.7
1.9
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
55
0.00
2.08
0.0
5.3
—
360.3
—
0
49
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
57
396
1.51
2.08
4.4
4.0
%
35.2
31.7
1.29
47
273
(3021960) Folate [Moles/volume] in Serum or Plasma
91
693
1.40
2.06
1.6
1.5
nmol/l
17.0
21.1
2.25
78
595
(40760888) Immunoglobulin light chains.free panel - Serum
14
63
2.26
2.03
4.3
4.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
342
3177
1.41
2.02
4.1
3.6
mmol/l
1.3
1.3
0.20
328
2938
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
73
536
1.44
2.02
1.3
1.3
u/ml
2.4
10.0
1.87
20
207
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
26
3.12
2.02
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
26
3.12
2.02
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
26
3.12
2.02
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
21
112
1.92
2.00
1.5
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
352
3290
1.43
1.98
4.5
3.9
mmol/l
1.4
1.4
0.22
338
3044
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
22
120
1.88
1.96
1.3
2.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
376
3561
1.53
1.95
18.2
11.0
—
—
—
0
0
(3004451) EKG impression Narrative
5
11
4.59
1.94
2.6
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
5
11
4.59
1.94
4.8
3.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
5
11
4.59
1.94
3.6
2.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
11
4.59
1.94
2.6
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
9
33
2.76
1.94
2.0
1.3
g/l
7.1
7.0
—
9
22
(3024139) IgG subclass 3 [Mass/volume] in Serum
9
33
2.76
1.94
2.0
1.3
g/l
0.4
0.3
—
9
21
(3028192) IgG subclass 2 [Mass/volume] in Serum
9
33
2.76
1.94
2.0
1.3
g/l
2.8
2.7
—
9
22
(3025159) Blasts/100 leukocytes in Blood
38
245
1.61
1.92
4.5
5.7
%
0.1
0.1
0.17
12
69
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
52
0.00
1.89
0.0
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
41
272
1.56
1.85
4.7
5.5
%
1.1
1.0
0.09
14
93
(3021440) Promyelocytes/100 leukocytes in Blood
39
257
1.57
1.81
4.7
5.6
%
0.1
0.1
0.30
12
81
(3007461) Platelets [#/volume] in Blood
398
3830
1.75
1.80
28.0
17.9
e9/l
233.5
247.9
4.84
393
3728
(3026389) Candida sp identified in Specimen by Organism specific culture
8
29
2.79
1.80
1.3
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
22
125
1.80
1.75
3.0
2.3
—
—
—
0
0
(1002224) Polysomnography panel
28
171
1.68
1.75
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
9
36
2.53
1.75
7.8
3.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
36
235
1.58
1.75
1.8
2.5
e9/l
3.6
4.1
0.51
29
187
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
147
1233
1.30
1.73
4.2
3.3
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
24
2.95
1.73
1.7
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
110
887
1.33
1.72
3.2
2.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
398
3835
1.72
1.72
28.0
17.9
e12/l
4.6
4.6
0.12
392
3724
(40765089) Chromosome analysis panel - Blood by G-banded
5
13
3.88
1.72
1.0
1.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
82
1.99
1.72
1.3
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
63
465
1.42
1.71
2.0
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
398
3836
1.72
1.70
28.0
17.9
e9/l
6.3
6.6
2.46
392
3723
(3000991) Gas panel - Venous blood
37
245
1.56
1.69
11.6
9.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
10
42
2.41
1.69
3.7
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
142
1.73
1.68
2.7
3.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
8
31
2.61
1.66
3.1
1.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
19
3.19
1.66
3.7
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
14
69
2.06
1.66
2.4
1.3
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
25
2.83
1.65
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
26
159
1.68
1.63
5.3
3.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
64
479
1.40
1.61
3.0
2.9
e6/l
4.2
1.5
0.40
32
262
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
70
2.03
1.61
1.2
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
11
50
2.23
1.58
6.3
6.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
12
57
2.14
1.56
1.8
1.2
u/ml
7.6
1.9
—
7
18
(3007853) Bacteria identified in Skin by Aerobe culture
53
386
1.43
1.55
2.1
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
354
3346
1.37
1.55
5.0
4.4
mmol/l
2.7
2.8
2.13
339
3090
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
33
2.45
1.54
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
5
15
3.36
1.52
2.0
2.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
18
101
1.82
1.51
2.3
1.8
—
—
—
0
0
(4094501)
15
80
1.91
1.46
1.1
1.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.46
2.3
1.9
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.46
2.3
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.46
2.3
1.9
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
11
52
2.15
1.45
7.1
3.4
kpa
9.6
8.6
0.87
11
52
(3013290) Carbon dioxide [Partial pressure] in Blood
11
52
2.15
1.45
7.1
3.4
kpa
4.9
4.9
0.07
11
52
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
19
110
1.76
1.45
1.7
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
17
95
1.82
1.45
6.8
4.3
kpa
9.0
8.5
0.40
17
88
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
16
3.15
1.44
2.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
16
3.15
1.44
1.2
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
36
247
1.50
1.43
4.6
5.3
%
0.2
0.4
—
9
66
(21494890) Protein electrophoresis panel - 24 hour Urine
6
23
2.63
1.37
1.7
2.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
87
701
1.30
1.37
4.8
3.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
49
363
1.40
1.32
8.6
7.1
mmol/l
104.0
104.3
0.18
49
357
(3037756) Immunofixation for Serum or Plasma
13
69
1.91
1.30
1.9
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
13
69
1.91
1.30
4.8
3.6
%
54.6
55.7
0.11
13
69
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
8
34
2.38
1.30
2.4
2.5
pg
34.1
33.3
—
8
34
(3003327) Ova and parasites identified in Stool by Light microscopy
17
99
1.75
1.29
2.4
1.6
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
48
2.11
1.28
3.7
1.8
—
—
—
0
0
(4268621)
9
44
2.07
1.27
3.7
2.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
44
2.07
1.27
2.3
2.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
99
819
1.27
1.27
1.6
1.6
mmol/l
1.4
1.4
0.05
79
691
(3019150) Specific gravity of Urine by Refractometry
86
700
1.29
1.25
4.8
3.3
kg/l
1.0
1.0
0.72
26
98
(3044927) Protein electrophoresis panel - Urine
6
25
2.42
1.25
1.7
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
6
25
2.42
1.25
1.0
1.6
mosm/kgh2o
281.0
289.1
—
6
19
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
19
2.65
1.22
1.2
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
19
2.65
1.22
1.2
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
13
71
1.86
1.20
7.1
3.9
u/ml
0.4
0.3
—
7
36
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
6
26
2.33
1.19
1.0
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
26
2.33
1.19
1.3
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
38
2.13
1.19
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
8
39
2.07
1.16
3.1
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
5
20
2.52
1.15
2.0
3.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
65
1.87
1.14
2.9
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
8
40
2.02
1.12
1.5
1.4
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
10
51
1.98
1.12
5.3
3.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
51
1.98
1.12
7.6
3.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
145
1.55
1.08
2.6
2.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
12
67
1.81
1.05
4.1
4.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
12
67
1.81
1.05
3.7
3.2
e9/l
3.5
4.0
0.23
12
67
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
90
1.69
1.05
1.1
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
130
1.57
1.04
1.2
1.3
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
24
163
1.50
1.04
1.8
1.7
—
—
—
0
0
(3022621) pH of Urine by Test strip
29
205
1.45
1.04
4.3
3.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
13
75
1.76
1.04
4.5
3.7
mmol/l
25.0
25.5
0.14
13
62
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5
22
2.29
1.03
1.0
1.2
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
7
34
2.08
1.03
1.6
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
7
35
2.02
1.00
1.4
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
34
250
1.39
0.99
2.4
2.6
ml/min/173m2
56.5
71.8
1.42
13
90
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
49
1.85
0.99
1.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
49
1.85
0.99
1.1
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
9
49
1.85
0.99
1.1
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
39
294
1.36
0.99
8.1
10.5
mmol/l
0.9
1.0
0.10
29
233
(3009542) Hematocrit [Volume Fraction] of Blood
333
3176
1.23
0.97
20.0
13.0
%
41.0
40.8
0.18
257
2410
(40768795) Lymph node Pathology biopsy report
7
36
1.96
0.97
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
51
1.78
0.95
1.1
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
16
101
1.61
0.95
2.9
3.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
37
1.91
0.94
1.1
1.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
29
2.08
0.89
1.0
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
19
129
1.50
0.85
1.6
1.6
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
45
1.79
0.84
1.1
1.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
10
58
1.74
0.80
6.9
4.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
33
1.83
0.79
3.7
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
26
191
1.39
0.79
1.3
1.2
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
98
0.50
0.79
2.0
1.4
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
11
67
1.66
0.76
2.0
1.4
pmol/l
71.1
230.7
0.52
11
67
(3010421) pH of Blood
11
67
1.66
0.76
7.9
3.2
ph
7.4
7.4
0.12
11
52
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
13
83
1.58
0.75
2.8
1.8
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
7
38
1.86
0.74
1.3
1.7
mmol/l
1.4
1.7
—
7
38
(4146454)
5
25
2.01
0.73
3.6
2.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
56
1.62
0.73
1.4
2.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
9
56
1.62
0.73
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
41
328
1.28
0.72
2.1
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
133
1197
1.16
0.72
5.0
4.5
ug/l
2.1
2.3
0.19
120
1077
(3000492) Spirometry study
42
338
1.27
0.71
1.7
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.71
3.8
1.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.71
3.8
1.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
213
1.34
0.70
1.5
1.2
iu/ml
58.8
133.9
—
9
93
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
85
1.55
0.69
2.8
1.8
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
12
77
1.57
0.69
4.8
1.5
—
—
—
0
0
(3020891) Body temperature
18
127
1.44
0.69
5.3
4.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
9
59
1.54
0.68
1.1
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
9
59
1.54
0.68
1.1
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.2
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
43
1.64
0.67
1.0
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
41
332
1.26
0.67
2.2
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
65
554
1.21
0.66
3.6
3.5
ng/l
69.7
410.7
2.96
49
400
(40768806) Pleura Pathology biopsy report
5
28
1.79
0.66
1.2
1.9
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
7
44
1.60
0.65
3.0
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
7
44
1.60
0.65
1.1
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
83
728
1.17
0.62
2.7
2.9
ug/l
0.9
0.7
0.72
53
465
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
18
130
1.40
0.62
12.9
17.1
—
—
—
0
0
(4306422)
8
52
1.55
0.59
1.1
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
53
1.52
0.58
3.1
1.5
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
35
1.72
0.58
1.2
2.1
%
90.1
89.8
—
6
35
(3021788) Differential panel - Synovial fluid
8
54
1.49
0.57
1.4
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
37
1.63
0.55
1.3
1.4
nmol/l
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
11
74
1.50
0.54
1.4
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
103
931
1.14
0.53
3.4
3.0
mmol/l
8.1
8.4
0.20
88
781
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
108
980
1.14
0.52
3.8
4.0
%
24.3
21.8
0.79
52
463
(3020682) Albumin/Creatinine [Ratio] in Urine
94
846
1.14
0.51
4.1
3.7
mg/mmol
3.1
6.6
1.45
64
529
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
51
437
1.19
0.51
2.1
2.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
45
382
1.20
0.50
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
34
281
1.23
0.49
3.9
3.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
45
1.56
0.49
2.0
2.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
45
1.56
0.49
1.3
1.3
—
—
—
0
0
(44790048)
7
46
1.53
0.48
2.7
1.8
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
7
46
1.53
0.48
3.0
1.3
—
—
—
0
0
(44790049)
7
46
1.53
0.48
2.7
1.8
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
46
1.53
0.48
3.0
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
7
46
1.53
0.48
3.0
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
46
1.53
0.48
3.0
1.3
—
—
—
0
0
(44806118)
7
46
1.53
0.48
2.7
1.8
—
—
—
0
0
(44790047)
7
46
1.53
0.48
2.7
1.8
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
10
143
0.69
0.48
1.5
1.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
75
668
1.15
0.48
1.9
2.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
102
1.39
0.48
1.2
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
237
2261
1.11
0.48
4.3
3.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
47
1.50
0.48
3.0
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
89
804
1.14
0.46
3.6
3.1
mg/l
18.3
375.3
1.52
59
519
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
184
1.26
0.44
1.3
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
51
1.38
0.44
1.1
1.7
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(4010399)
30
249
1.22
0.43
1.9
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
5
32
1.57
0.42
1.2
1.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
33
1.52
0.41
22.2
4.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
16
0.00
0.41
0.0
1.1
—
7.4
—
0
16
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
311
3024
1.11
0.39
5.8
5.0
mmol/mol
38.1
39.0
0.82
298
2824
(3035933) Granulocytes/100 leukocytes in Blood
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
66
1.37
0.38
1.2
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
9
68
1.33
0.38
1.9
1.8
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
5
37
1.36
0.37
3.6
1.3
—
48.8
—
0
8
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
45
395
1.16
0.36
2.0
2.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
78
0.64
0.36
1.6
1.6
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
42
1.43
0.35
1.8
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
35
303
1.17
0.34
5.9
2.9
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
13
100
1.31
0.34
1.3
1.8
pmol/l
217.4
235.6
0.37
13
94
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
3.2
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
10
74
1.36
0.32
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
12
154
0.77
0.32
1.0
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
47
1.28
0.32
1.5
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
251
0.83
0.32
2.2
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
102
1.28
0.30
1.5
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
224
1.17
0.28
1.9
2.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
8
66
1.22
0.27
1.3
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
5
71
0.70
0.26
1.4
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
71
0.70
0.26
1.4
1.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
5
73
0.68
0.26
1.4
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
5
73
0.68
0.26
1.4
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
5
73
0.68
0.26
1.4
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
5
73
0.68
0.26
1.4
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
142
1.21
0.25
1.2
2.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
132
1258
1.07
0.25
2.6
2.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
97
915
1.08
0.24
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
147
0.81
0.23
1.8
1.8
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
42
1.19
0.21
2.4
1.6
%
12.6
13.1
—
5
42
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
12
0.00
0.21
0.0
1.0
—
-3.9
—
0
6
(3024891) Influenza virus A+B Ag [Presence] in Specimen
12
99
1.22
0.20
1.2
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
50
1.20
0.20
2.7
1.6
—
—
—
0
0
(3019060) Gas panel - Arterial blood
20
175
1.15
0.19
4.0
7.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
166
1.15
0.18
1.1
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
7
60
1.17
0.18
1.0
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
20
176
1.14
0.17
1.5
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
67
0.74
0.17
1.6
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
68
0.73
0.17
1.8
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
33
360
0.91
0.17
1.7
1.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
12
101
1.19
0.16
1.0
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
38
411
0.92
0.16
1.3
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
8
71
1.13
0.16
2.8
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
8
71
1.13
0.16
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
73
1.10
0.16
2.3
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
12
102
1.18
0.15
1.0
1.1
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
16
181
0.88
0.14
1.1
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
123
1.14
0.12
2.7
2.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
12
104
1.16
0.12
1.0
1.2
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
15
167
0.89
0.11
1.3
2.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
184
1.09
0.09
1.9
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
27
253
1.07
0.08
4.3
3.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
64
0.78
0.08
1.4
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
64
0.78
0.08
1.4
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
64
1.10
0.08
2.4
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
85
1.06
0.07
1.7
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
87
1.04
0.07
1.2
2.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
10
89
1.13
0.07
1.2
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
19
177
1.08
0.06
1.2
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
88
862
1.03
0.05
4.3
3.4
estimate
0.0
0.0
0.80
34
296
(3028300) Cannabinoids [Presence] in Urine
19
179
1.06
0.05
1.2
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
19
179
1.06
0.05
1.2
1.9
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
19
179
1.06
0.05
1.2
1.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
34
329
1.04
0.03
1.7
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
44
429
1.03
0.03
1.5
1.4
—
—
—
0
0
(4034850)
11
102
1.08
0.03
7.6
11.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
15
142
1.06
0.02
2.1
1.7
mg/l
1.4
3.5
—
9
101
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
387
0.98
0.01
8.3
6.2
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
12
126
0.95
0.00
1.7
1.4
g/l
1.1
1.2
0.50
12
121
(3001019) Free T4 and TSH panel - Serum or Plasma
17
166
1.03
0.00
1.2
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
36
356
1.01
0.00
2.1
1.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
59
0.85
0.00
1.2
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
51
0.98
0.00
1.6
1.3
—
—
—
0
0
(3022229) Phosphate [Moles/volume] in Urine
0
6
0.00
0.00
0.0
2.0
—
21.1
—
0
6
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
23.7
—
0
6
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
2.1
—
0
6
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
8
0.00
0.00
0.0
16.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
0
9
0.00
0.00
0.0
1.1
—
36.0
—
0
9
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
65
0.92
0.00
1.2
1.1
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
6
61
0.98
0.00
1.7
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
8
86
0.93
0.00
1.6
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
0
7
0.00
0.00
0.0
1.0
—
170.9
—
0
7
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
66
0.91
0.00
1.0
1.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
8
0.00
0.00
0.0
7.3
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
17.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
1.1
—
0
7
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
53
0.94
0.00
1.2
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint E4_PORBILIR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_PORBILIR | 1.937 [1.55, 2.43] | < 0.001 |
| Birth year | 0.994 [0.99, 1.0] | 0.166 |
During the follow-up period (1.1.1998 — 31.12.2019), 140 out of 1058 females with E4_PORBILIR died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| E4_PORBILIR | 1.442 [1.18, 1.76] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.113 |
During the follow-up period (1.1.1998 — 31.12.2019), 232 out of 1474 males with E4_PORBILIR died.
Mortality risk
Mortality risk for people of age
years, who have E4_PORBILIR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.134% | 0.283% |
| 5 | 1.176% | 1.95% |
| 10 | 2.932% | 4.595% |
| 15 | 5.514% | 8.699% |
| 20 | 9.052% | 14.938% |
Relationships between endpoints
↥Index endpoint: E4_PORBILIR – Disorders of porphyrin and bilirubin metabolism
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data